Update on antimicrobial peptides: key elements in Orthoflavivirus infection - an overview

Area of Science:

• Virology
• Immunology
• Infectious Diseases

Background:

• Flaviviridae viruses, transmitted by Aedes mosquitoes, cause significant global health issues, including febrile, hemorrhagic, and neurodegenerative diseases.
• Emerging flavivirus outbreaks are exacerbated by climate change, increasing vector range and disease transmission.
• Current therapeutic options and vaccines for Orthoflavivirus infections are lacking, necessitating research into novel treatment strategies.

Purpose of the Study:

• To review and synthesize current knowledge on antimicrobial peptides (AMPs) in the context of Orthoflavivirus infections.
• To highlight the potential of AMPs as a therapeutic strategy against flavivirus-induced illnesses.
• To underscore the importance of understanding the innate immune response involving AMPs for developing new treatments.

Main Methods:

• Literature review and synthesis of existing research on Flaviviridae, Orthoflavivirus, and antimicrobial peptides.
• Analysis of the role of AMPs in innate immunity against viral pathogens.
• Focus on studies investigating AMPs in relation to Orthoflavivirus infections.

Main Results:

• Antimicrobial peptides (AMPs) are key components of the innate immune system with demonstrated antiviral properties.
• The specific role and efficacy of AMPs against Orthoflavivirus infections are not yet fully elucidated but show promise.
• Research suggests that stimulating or administering AMPs could be a viable therapeutic approach.

Conclusions:

• Antimicrobial peptides represent a promising avenue for developing novel therapeutics against emerging Orthoflavivirus infections.
• Further research into AMPs' mechanisms of action and clinical application is crucial for combating flavivirus diseases.
• Understanding the interplay between AMPs and the host immune response is vital for advancing flavivirus treatment strategies.